Acro Biomedical Co., Ltd.
Acro Biomedical Co., Ltd., headquartered in the United States, is a leading player in the biomedical industry, specialising in innovative medical devices and advanced healthcare solutions. Founded in 2015, the company has rapidly established itself as a key provider of cutting-edge products that enhance patient care and improve clinical outcomes. With a strong operational presence across North America and Europe, Acro Biomedical focuses on developing unique technologies in areas such as regenerative medicine and surgical instruments. Their core offerings, including biocompatible materials and precision-engineered devices, are distinguished by their commitment to quality and efficacy. Recognised for its contributions to the field, Acro Biomedical has achieved significant milestones, positioning itself as a trusted name among healthcare professionals and institutions. The company continues to drive advancements in biomedical technology, ensuring a healthier future for patients worldwide.
DitchCarbon Score
How does Acro Biomedical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Acro Biomedical Co., Ltd.'s score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Acro Biomedical Co., Ltd.'s reported carbon emissions
Acro Biomedical Co., Ltd., headquartered in the US, currently does not have any publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or commitments outlined in their initiatives. Without specific emissions figures or reduction goals, it is challenging to assess their climate impact or commitments in detail. However, the absence of data suggests a potential opportunity for the company to enhance transparency regarding their carbon footprint and climate strategies. As the industry increasingly prioritises sustainability, Acro Biomedical may benefit from establishing clear climate commitments and measurable targets to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Acro Biomedical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
